Results for this period
Interim period (second quarter)1 April 2026–30 September 2026ConsolidatedJapanese GAAPThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
The Fine Chemicals business saw increased sales of pesticide intermediates but decreased sales of resin raw materials. The Functional Materials business benefited from higher selling prices and increased sales of rubber chemicals. The Resin Additives business saw higher selling prices for plasticizers in response to higher raw material prices, increased sales of varnishes, and higher selling prices. The Contract Chemical Analysis business saw decreased sales of services such as working-environment measurements.
No applicable matters.
| Item | Details |
|---|---|
| Fiscal Period Classification | Interim period (second quarter) |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 April 2026–30 September 2026 |
| Net Sales | ¥16,165 million (YoY -8.6%) |
| Operating profit | ¥359 million (YoY -74.5%) |
| Ordinary income | ¥394 million (YoY -72.5%) |
| Profit attributable to owners of the parent | ¥218 million (YoY -79.3%) |
| Net income per share | ¥15.20 |
| Equity ratio | End of the current fiscal period 63 / End of previous period 63.2 |
| Total assets | ¥31,057 million |
| Net assets | ¥19,563 million |
| Full-year earnings forecast | Net Sales ¥34,000 million (YoY +2.4%) / Operating profit ¥500 million (YoY -75.6%) / Ordinary income ¥550 million (YoY -73.8%) / Net income ¥300 million (YoY -80.4%) |
| Revision to Earnings Forecast | Net Sales Not disclosed → ¥34,000 million / Operating profit Not disclosed → ¥500 million / Ordinary income Not disclosed → ¥550 million / Net income Not disclosed → ¥300 million |
| Annual Dividend Forecast | ¥36 → ¥6（-83.3%） |
| Segment revenue | Chemicals ¥15,907 million (YoY -8.7%) / Contract chemical analysis services ¥258 million (YoY -6.0%) |
| Segment profit | Chemicals ¥375 million / Contract chemical analysis services ¥-17 million |
| Depreciation and amortization | ¥910 million |
| Breakdown of extraordinary income (loss) | Extraordinary income Not disclosed / Extraordinary loss Loss on retirement of non-current assets ¥38 million |
| Disclosure regarding the going concern assumption | No applicable matters. |
| Change in accounting policy | Changes due to revisions to standards None / Other changes None / Change in accounting estimate None / Restatement None |
| Changes in the scope of consolidation | Whether applicable None / New Not disclosed / Excluded Not disclosed / Company name Not disclosed |
| Availability of Supplementary Financial Results Materials | None |
| Availability of Financial Results Briefing | Whether applicable Yes / Subject person For institutional investors and analysts |
| Issued Shares at Period-End | 14,440,000 shares |
| Treasury Shares at Period-End | 111,441 shares |
| Factors Behind Changes in Business Performance | The Fine Chemicals business saw increased sales of pesticide intermediates but decreased sales of resin raw materials. The Functional Materials business benefited from higher selling prices and increased sales of rubber chemicals. The Resin Additives business saw higher selling prices for plasticizers in response to higher raw material prices, increased sales of varnishes, and higher selling prices. The Contract Chemical Analysis business saw decreased sales of services such as working-environment measurements. |
Items this document does not state (11)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.In the Fine Chemicals business, sales of resin raw materials declined, while in the Contract Chemical Analysis business, sales of services such as working-environment measurements decreased. Meanwhile, the Functional Materials business benefited from higher selling prices and increased sales of rubber chemicals, while the Resin Additives business saw higher selling prices for plasticizers in response to higher raw material prices, as well as increased sales of varnishes.